Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kurtz, JE; Deplanque, G; Borel, C; Mathelin, C; Prevost, G; Poulin, G; Barats, JC; Bergerat, JP; Chapelle-Marcillac, I; Bardonnet, M; Dufour, P
   Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer
   ANNALS OF ONCOLOGY
   
   J.E. Kurtz et al., "Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer", ANN ONCOL, 11(2), 2000, pp. 229-230
2. Quantin, X; Riviere, A; Daures, JP; Oliver, P; Comte-Bardonnet, M; Khial, F; Marcillac, I; Pujol, JL
   Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer - Searching for the maximal tolerated dose
   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
   
   X. Quantin et al., "Phase I-II study of high dose epirubicin plus cisplatin in unresectable non-small-cell lung cancer - Searching for the maximal tolerated dose", AM J CL ONC, 23(2), 2000, pp. 192-196
3. REY RA; LHOMME C; MARCILLAC I; LAHLOU N; DUVILLARD P; JOSSO N; BIDART JM
   ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA-CELL TUMORS OF THE OVARY - COMPARATIVE-STUDY WITH SERUM ALPHA-INHIBIN AND ESTRADIOL
   American journal of obstetrics and gynecology
   
   R.A. Rey et al., "ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA-CELL TUMORS OF THE OVARY - COMPARATIVE-STUDY WITH SERUM ALPHA-INHIBIN AND ESTRADIOL", American journal of obstetrics and gynecology, 174(3), 1996, pp. 958-965
4. HOUSSEAU F; ROUASFREISS N; BENIFLA JL; MARCILLAC I; ROY M; TROALEN F; FERNANDEZ H; PRAPOTNICH D; VALENCIEN G; BOUGARAN J; COTTU P; CULINE S; DROZ JP; BIDART JM; BELLET D
   REACTION OF PERIPHERAL-BLOOD LYMPHOCYTES TO THE HUMAN CHORIONIC-GONADOTROPIN BETA-SUBUNIT IN PATIENTS WITH PRODUCTIVE TUMORS
   International journal of cancer
   
   F. Housseau et al., "REACTION OF PERIPHERAL-BLOOD LYMPHOCYTES TO THE HUMAN CHORIONIC-GONADOTROPIN BETA-SUBUNIT IN PATIENTS WITH PRODUCTIVE TUMORS", International journal of cancer, 63(5), 1995, pp. 633-638
5. MARCILLAC I; COTTU P; THEODORE C; TERRIERLACOMBE MJ; BELLET D; DROZ JP
   FREE HCG-BETA SUBUNIT AS TUMOR-MARKER IN UROTHELIAL CANCER
   Lancet
   
   I. Marcillac et al., "FREE HCG-BETA SUBUNIT AS TUMOR-MARKER IN UROTHELIAL CANCER", Lancet, 341(8856), 1993, pp. 1354-1355
6. MARCILLAC I; IBRAHIM A; HAYAT M
   THROMBOTIC DISORDERS IN CANCER-PATIENTS
   Bulletin du cancer
   
   I. Marcillac et al., "THROMBOTIC DISORDERS IN CANCER-PATIENTS", Bulletin du cancer, 80(10), 1993, pp. 845-851